Bradley A. Stohr - Concepedia

Author

Bradley A. Stohr

University of California, San Francisco ORCID

Also Known As

B. Stohr, B. Stöhr, B.A. Stohr, Bradley A. Stohr, Bradley A Stohr, Bradley A. Stohr, Bradley Stohr

198

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco UCSF Helen Diller Family Comprehensive Cancer Center The University of Texas Southwestern Medical Center Duke University Duke Medical Center

About

Bradley A. Stohr is an author at University of California, San Francisco specializing in medicine, tumor biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	24	1.6K
2	Natural Sciences	4	4	96
3	Health Sciences	2	2	33
4	Engineering	1	1	63
5	Biochemistry	1	1	47

Bradley A. Stohr

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells Johanna Flach, Sietske T. Bakker, Mary Mohrin, Nature Developmental BiologyHaematopoietic Stem CellsMedicineAdult Stem CellStem Cell Mobilization	2014	612
Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states Hanbing Song, H Weinstein, Paul Allegakoen, Nature Communications	2022	243
Broad Distribution of Hepatocyte Proliferation in Liver Homeostasis and Regeneration Feng Chen, Robert J. Jimenez, Khushbu Sharma, Cell stem cell Developmental BiologyHepatologyLiver PhysiologyHistopathologyPathology	2019	235
Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors Erin R. Rudzinski, Christina M. Lockwood, Bradley A. Stohr, The American Journal of Surgical Pathology	2018	201
Heterogeneity in <i>NECTIN4</i> Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin Carissa Chu, Martin Sjöström, Emily A. Egusa, Clinical Cancer Research	2021	150
Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors Jessica L. Davis, Christina M. Lockwood, Bradley A. Stohr, The American Journal of Surgical Pathology Tumoral PathologyPediatric Brain TumorsVariant Ntrk FusionsNtrk FusionsVariant Ntrk Tumors	2018	134
“Renal Cell Carcinoma With Leiomyomatous Stroma” Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity Rajal B. Shah, Bradley A. Stohr, Zheng Jin Tu, The American Journal of Surgical Pathology	2019	107
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells Jonathan Chou, Kai Trepka, Martin Sjöström, European Urology Oncology Genitourinary CancerUrothelial CarcinomaPathologyCancer GenomicsEnfortumab Vedotin-resistant Cells	2022	81
Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity Su-Yang Liu, Nancy M. Joseph, Ajay Ravindranathan, Modern Pathology Intratumoral HeterogeneityMedicinePathologyCancer GenomicsProtein Kinase	2016	74
The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres Amanda Frank, Duy Tran, Roy W. Qu, PLoS Genetics Genome InstabilityEngineeringOncogenic AgentMedicineTelomerase Activity	2015	63

Page 1